Status:
UNKNOWN
Thromboelastography During Surgery for Malignant Pleural Mesothelioma
Lead Sponsor:
Brigham and Women's Hospital
Conditions:
Coagulopathy
Mesothelioma
Eligibility:
All Genders
18+ years
Brief Summary
Surgery for malignant pleural mesothelioma is complex and prolonged, and may involve significant blood loss with considerable blood and product transfusion. Thromboelastography (TEG) is a global assay...
Detailed Description
Thromboelastography can provide more in-depth and quicker analysis of the complex coagulation processes during surgery
Eligibility Criteria
Inclusion
- Adult male or female patients undergoing elective surgery for malignant pleural mesothelioma
Exclusion
- Unwilling or unable to provide consent
- History of bleeding disorder
- On medications that may affect hemostasis
Key Trial Info
Start Date :
September 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01912547
Start Date
September 1 2013
End Date
December 1 2015
Last Update
January 30 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115